Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab.
Sonoki
Takashi
T
Department of Hematology/Oncology, Wakayama Medical University, 811-1 Kimi-idera, Wakayama, 633-1611, Japan. sonoki@wakayama-med.ac.jp.
Li
Yaqiong
Y
2nd Department of Pathology, Wakayama Medical University, Wakayama, Japan.
Miyanishi
Setsuko
S
Tenri Institute of Medical Research, Nara, Japan.
Nakamine
Hirokazu
H
Division of Pathology and Immunology, Kansai University of Health Sciences, Osaka, Japan.
Hanaoka
Nobuyoshi
N
Department of Hematology/Oncology, Wakayama Medical University, 811-1 Kimi-idera, Wakayama, 633-1611, Japan.
Matsuoka
Hiroshi
H
Department of Hematology/Oncology, Wakayama Medical University, 811-1 Kimi-idera, Wakayama, 633-1611, Japan.
Mori
Ichiro
I
2nd Department of Pathology, Wakayama Medical University, Wakayama, Japan.
Nakakuma
Hideki
H
Department of Hematology/Oncology, Wakayama Medical University, 811-1 Kimi-idera, Wakayama, 633-1611, Japan.